Administration of a low IL-2 dose to a cohort of 190 patients with SS restored the number of Tregs in the peripheral blood, which was significantly lower in patients, whereas the proportion of Th17 cells was not significantly changed in comparison to the healthy control group. Here, IL2 is linked to synovial sarcoma.